Cargando…
Impact of emollient therapy for preterm infants in the neonatal period on child neurodevelopment in Bangladesh: an observational cohort study
BACKGROUND: Topical treatment with sunflower seed oil (SSO) or Aquaphor® reduced sepsis and neonatal mortality in hospitalized preterm infants <33 weeks’ gestational age in Bangladesh. We sought to determine whether the emollient treatments improved neurodevelopmental outcomes during early childh...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8152128/ https://www.ncbi.nlm.nih.gov/pubmed/34039435 http://dx.doi.org/10.1186/s41043-021-00248-9 |
_version_ | 1783698540951764992 |
---|---|
author | Darmstadt, Gary L. Khan, Naila Z. Rosenstock, Summer Muslima, Humaira Parveen, Monowara Mahmood, Wajeeha Ahmed, A. S. M. Nawshad Uddin Chowdhury, M. A. K. Azad Zeger, Scott Saha, Samir K. |
author_facet | Darmstadt, Gary L. Khan, Naila Z. Rosenstock, Summer Muslima, Humaira Parveen, Monowara Mahmood, Wajeeha Ahmed, A. S. M. Nawshad Uddin Chowdhury, M. A. K. Azad Zeger, Scott Saha, Samir K. |
author_sort | Darmstadt, Gary L. |
collection | PubMed |
description | BACKGROUND: Topical treatment with sunflower seed oil (SSO) or Aquaphor® reduced sepsis and neonatal mortality in hospitalized preterm infants <33 weeks’ gestational age in Bangladesh. We sought to determine whether the emollient treatments improved neurodevelopmental outcomes during early childhood. METHODS: 497 infants were randomized to receive SSO, Aquaphor®, or neither through the neonatal period or hospital discharge. 159 infant survivors were enrolled in the longitudinal follow-up study using a validated Rapid Neurodevelopmental Assessment tool and the Bayley Scales of Infant Development II (BSID II) administered at three-monthly intervals for the first year and thereafter at six-monthly intervals. Lowess smoothing was used to display neurodevelopmental status across multiple domains by age and treatment group, and Generalized Estimating Equations (GEE) were used to compare treatment groups across age points. RESULTS: 123 children completed at least one follow-up visit. Lowess graphs suggest that lower proportions of children who received massage with either SSO or Aquaphor® had neurodevelopmental delays than control infants in a composite outcome of disabilities. In GEE analysis, infants receiving SSO showed a significant protective effect on the development of fine motor skills [odds ratio (OR) 0.92, 95% confidence interval (CI) 0.86–0.98, p=0.006]. The Psychomotor Development Index (PDI) in the BSID II showed significantly lower disability rates in the Aquaphor group (23.6%) compared to the control (55.2%) (OR 0.21, 95% CI 0.06–0.72, p=0.004). CONCLUSIONS: Emollient massage of very preterm, hospitalized newborn infants improved some child neurodevelopmental outcomes over the first 2 years of follow-up. Findings warrant further confirmatory research. TRIAL REGISTRATION: ClinicalTrials.gov (98-04-21-03-2) under weblink https://clinicaltrials.gov/ct2/show/NCT00162747 |
format | Online Article Text |
id | pubmed-8152128 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-81521282021-05-26 Impact of emollient therapy for preterm infants in the neonatal period on child neurodevelopment in Bangladesh: an observational cohort study Darmstadt, Gary L. Khan, Naila Z. Rosenstock, Summer Muslima, Humaira Parveen, Monowara Mahmood, Wajeeha Ahmed, A. S. M. Nawshad Uddin Chowdhury, M. A. K. Azad Zeger, Scott Saha, Samir K. J Health Popul Nutr Research Article BACKGROUND: Topical treatment with sunflower seed oil (SSO) or Aquaphor® reduced sepsis and neonatal mortality in hospitalized preterm infants <33 weeks’ gestational age in Bangladesh. We sought to determine whether the emollient treatments improved neurodevelopmental outcomes during early childhood. METHODS: 497 infants were randomized to receive SSO, Aquaphor®, or neither through the neonatal period or hospital discharge. 159 infant survivors were enrolled in the longitudinal follow-up study using a validated Rapid Neurodevelopmental Assessment tool and the Bayley Scales of Infant Development II (BSID II) administered at three-monthly intervals for the first year and thereafter at six-monthly intervals. Lowess smoothing was used to display neurodevelopmental status across multiple domains by age and treatment group, and Generalized Estimating Equations (GEE) were used to compare treatment groups across age points. RESULTS: 123 children completed at least one follow-up visit. Lowess graphs suggest that lower proportions of children who received massage with either SSO or Aquaphor® had neurodevelopmental delays than control infants in a composite outcome of disabilities. In GEE analysis, infants receiving SSO showed a significant protective effect on the development of fine motor skills [odds ratio (OR) 0.92, 95% confidence interval (CI) 0.86–0.98, p=0.006]. The Psychomotor Development Index (PDI) in the BSID II showed significantly lower disability rates in the Aquaphor group (23.6%) compared to the control (55.2%) (OR 0.21, 95% CI 0.06–0.72, p=0.004). CONCLUSIONS: Emollient massage of very preterm, hospitalized newborn infants improved some child neurodevelopmental outcomes over the first 2 years of follow-up. Findings warrant further confirmatory research. TRIAL REGISTRATION: ClinicalTrials.gov (98-04-21-03-2) under weblink https://clinicaltrials.gov/ct2/show/NCT00162747 BioMed Central 2021-05-26 /pmc/articles/PMC8152128/ /pubmed/34039435 http://dx.doi.org/10.1186/s41043-021-00248-9 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Article Darmstadt, Gary L. Khan, Naila Z. Rosenstock, Summer Muslima, Humaira Parveen, Monowara Mahmood, Wajeeha Ahmed, A. S. M. Nawshad Uddin Chowdhury, M. A. K. Azad Zeger, Scott Saha, Samir K. Impact of emollient therapy for preterm infants in the neonatal period on child neurodevelopment in Bangladesh: an observational cohort study |
title | Impact of emollient therapy for preterm infants in the neonatal period on child neurodevelopment in Bangladesh: an observational cohort study |
title_full | Impact of emollient therapy for preterm infants in the neonatal period on child neurodevelopment in Bangladesh: an observational cohort study |
title_fullStr | Impact of emollient therapy for preterm infants in the neonatal period on child neurodevelopment in Bangladesh: an observational cohort study |
title_full_unstemmed | Impact of emollient therapy for preterm infants in the neonatal period on child neurodevelopment in Bangladesh: an observational cohort study |
title_short | Impact of emollient therapy for preterm infants in the neonatal period on child neurodevelopment in Bangladesh: an observational cohort study |
title_sort | impact of emollient therapy for preterm infants in the neonatal period on child neurodevelopment in bangladesh: an observational cohort study |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8152128/ https://www.ncbi.nlm.nih.gov/pubmed/34039435 http://dx.doi.org/10.1186/s41043-021-00248-9 |
work_keys_str_mv | AT darmstadtgaryl impactofemollienttherapyforpreterminfantsintheneonatalperiodonchildneurodevelopmentinbangladeshanobservationalcohortstudy AT khannailaz impactofemollienttherapyforpreterminfantsintheneonatalperiodonchildneurodevelopmentinbangladeshanobservationalcohortstudy AT rosenstocksummer impactofemollienttherapyforpreterminfantsintheneonatalperiodonchildneurodevelopmentinbangladeshanobservationalcohortstudy AT muslimahumaira impactofemollienttherapyforpreterminfantsintheneonatalperiodonchildneurodevelopmentinbangladeshanobservationalcohortstudy AT parveenmonowara impactofemollienttherapyforpreterminfantsintheneonatalperiodonchildneurodevelopmentinbangladeshanobservationalcohortstudy AT mahmoodwajeeha impactofemollienttherapyforpreterminfantsintheneonatalperiodonchildneurodevelopmentinbangladeshanobservationalcohortstudy AT ahmedasmnawshaduddin impactofemollienttherapyforpreterminfantsintheneonatalperiodonchildneurodevelopmentinbangladeshanobservationalcohortstudy AT chowdhurymakazad impactofemollienttherapyforpreterminfantsintheneonatalperiodonchildneurodevelopmentinbangladeshanobservationalcohortstudy AT zegerscott impactofemollienttherapyforpreterminfantsintheneonatalperiodonchildneurodevelopmentinbangladeshanobservationalcohortstudy AT sahasamirk impactofemollienttherapyforpreterminfantsintheneonatalperiodonchildneurodevelopmentinbangladeshanobservationalcohortstudy |